Eight Roads, a global venture capital firm backed by Fidelity, launched its latest dedicated technology fund for China.
Eight Roads China Technology Fund V, has US$350m of capital to deepen the firm’s focus on core technology areas accompanied by a deep thematic investment approach.
Since its first investment in China in the 1990s, Eight Roads has evolved with the development of the technology industry in the country and remains committed to supporting local entrepreneurs to develop the next generation of global technology companies with its deep domain expertise and global network.
Led by Jarlon Tsang, Managing Partner and Head of Eight Roads Ventures China, and Ted Chua, Senior Partner, Eight Roads Ventures China has backed over 130 companies in the country’s healthcare and technology sectors such as Alibaba, Adagene, Asia Info, BangEr, Eyebright, FenBeiTong, Innovent, Innovusion, Kyligence, Medbanks, MediTrust, PingPong, Pony.ai, WuXi Apptec, etc.
Globally, the Eight Roads platform has backed more than 300 companies including AppsFlyer, Cazoo, Icertis, Made.com, Neo4j, Paidy, Shadowfax, and Spendesk, to name a few. The firm is managing over $8bn of assets across offices in China, India, Japan, Europe and the US.